OBJECTIVE: From early to term pregnancy, the placenta normally presents progressive aging promoting cell death leading to decreased activity related to normal post-term changes. While previous studies in placentas from small fetuses suggested an accelerated placental aging process, it is unclear whether SGA -with apparent normal placental function by ultrasound-encompass premature placental aging or whether this phenomenon is restricted to FGR. The aim of this study was to perform a comprehensive assessment of the placental aging process through senescence and apoptotic markers in late-onset small fetuses classified as SGA or FGR. STUDY DESIGN: A nested case-control study in singleton pregnancies delivering at term including 21 normally grown fetuses and 36 small fetuses classified into SGA (if birthweight was between the 3rd and 9th centile and normal fetoplacental Doppler; n¼18) and FGR (if birthweight <3rd centile and/or abnormal cerebroplacental ratio or uterine artery Doppler; n¼18). Telomerase activity, telomere length and RNA expression of senescence (Sirtuin 1,3,6) and apoptotic markers (p53, p21, BAX, Caspase 3 and 9) were analyzed in placental samples collected at birth. RESULTS: Compared with normally grown fetuses, both SGA and FGR presented signs of accelerated placental aging including lower telomerase activity (controls meanAESD 12.8% AE 6.6 vs SGA 7.98% AE 4.2 vs FGR 7.79% AE 4.6, p¼0.008), shorter telomeres (controls 1.20 T/S AE 0.6 vs SGA 1.08 T/S AE 0.9 vs FGR 0.66 T/S AE 0.5, p¼0.017), and reduced Sirtuin1 RNA expression (controls 1.55 2 -DDCt AE 0. OBJECTIVE: Cardiovascular risk is believed to be increased in the offsprings of pregnancies complicated by preeclampsia (PE) and/or fetal growth restriction (FGR). The objective was to describe fetal cardiac structure and function in pregnancies complicated by PE and/or FGR as compared to fetuses of uncomplicated pregnancies. STUDY DESIGN: Prospective cohort study including normotensive FGR (n¼36), PE with (n¼42) and without FGR (n¼35) as well as uncomplicated pregnancies (n¼111). Fetal echocardiography was performed at diagnosis of PE or FGR and controls were matched for gestational age at the ultrasound. Cord blood concentrations of Btype natriuretic peptide (BNP) and Troponin I were measured at delivery.
RESULTS:
Fetuses of pregnancies complicated with PE and/or FGR showed ultrasonographic features of cardiac remodeling such as increased cardiothoracic ratio, more spherical ventricles with decreased left sphericity index, decreased right sphericity index, and high myocardial relative wall thickness compared to controls (all p values <0.001) ( Table 1) . Fetal cardiac dysfunction and injury were also documented in fetuses with FGR and PE, reflected in significantly higher myocardial performance index [1.48 (0.97 e 2.08) in normotensive FGR, 1.15 (0.75e2.17) in PE without FGR and 1.45 (0.54e1.94) in PE+FGR vs. 0.78 (0.32e1.41) in controls; p<0.001), and significantly higher cord blood concentrations of BNP and Troponin I compared to controls (all p values <0.001) (Figure 1) . CONCLUSION: Both, PE and FGR are associated with fetal cardiovascular remodeling. Future research is needed to better elucidate the mechanism(s) underlying these conditions.
